About cardiovalve
cardiovalve is a Healthcare company based in Or Yehuda (Israel) founded in 2011, and was acquired by Venus MedTech in December 2021. Its chief executive is Amir Gross. cardiovalve offers products and services including Cardiovalve System, TTVR, and TMVR. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
Cardiovalve was founded in 2011 in Or Yehuda, Israel, within the medical device sector focused on cardiology. A transfemoral transcatheter system for mitral and tricuspid valve replacement is being developed to enable delivery without open-heart surgery. Features such as a short frame to limit ventricular protrusion and lower LVOT obstruction risk, along with secure anchoring and improved sealing against paravalvular leaks, are incorporated. The device remains investigational at this stage.
- Headquarters Or Yehuda, Israel
- SectorsHealthcare
- Email••••••••
- Website cardiovalve.com
- Social LinkedIn
- Acquired by Venus MedTech (Dec 2021)
- Investors
- Acquired byVenus MedTech
(Dec 2021)
Products & Services of cardiovalve
cardiovalve offers a comprehensive portfolio of products and services, including Cardiovalve System, TTVR, and TMVR.
Transfemoral system for replacing mitral and tricuspid heart valves
Transcatheter therapy for tricuspid valve replacement in cardiac care
Transcatheter system for mitral valve replacement procedures
Investors in cardiovalve
cardiovalve has secured backing from 1 investor. Prominent investors backing the company include Venus MedTech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures. | 2009 | venusmedtech.com | Hangzhou, China |
Investor details for cardiovalve
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of cardiovalve
1 people are tracked at cardiovalve (1 in leadership).
| Name | Role | Group |
|---|---|---|
Amir Gross | CEO | Leadership |
Complete people profiles for cardiovalve
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of cardiovalve
2 dated milestones of cardiovalve across 10 years, from founding to its latest funding, stage changes and deals.
- Founded cardiovalve is founded.
- Exit Acquired by Venus MedTech.
Competitors of cardiovalve
cardiovalve has 10 listed competitors in our database, 10 of them funded. They include Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| shockwavemedical.com | 2009 | Santa Clara, United States | $147.5M | 1,394 | Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed. | |
| cardiacdimensions.com | 2001 | Kirkland, United States | $260.8M | 31 | Invasive cardiac implants for heart failure treatment are developed. | |
| venusmedtech.com | 2009 | Hangzhou, China | $37M | – | Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures. | |
| pi-cardia.net | 2009 | Rehovot, Israel | $40M | – | Non-implant devices for cardiac valve repair are developed and manufactured. | |
| symetis.com | 2001 | Ecublens, Switzerland | $56.66M | – | Minimally invasive heart valve replacement devices are developed and marketed. | |
| peijiamedical.com | 2012 | Suzhou, China | $110.08M | – | Medical devices for cardiac and cerebrovascular treatments are developed. | |
| jenavalve.com | 2006 | Irvine, United States | $363.7M | 198 | Pericardial transcatheter aortic valve replacement systems are provided. | |
| neochord.com | 2007 | Eden Prairie, United States | $108.67M | 7 | Minimally invasive mitral valve repair devices are developed and provided. | |
| capstanmedical.com | 2020 | Santa Cruz, United States | $141.4M | – | Medical devices for structural heart disease treatment are developed. | |
| tricares.com | 2013 | Aschheim, Germany | $102.84M | – | Minimally invasive tricuspid valve replacement system is developed. |
Detailed competitors of cardiovalve
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as cardiovalve (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cardiovalve
Complete news archive for cardiovalve
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about cardiovalve
cardiovalve was founded in 2011.
cardiovalve is headquartered in Or Yehuda, Israel.
Amir Gross is the current CEO of cardiovalve.
Cardiovalve was founded in 2011 in Or Yehuda, Israel, within the medical device sector focused on cardiology. A transfemoral transcatheter system for mitral and tricuspid valve replacement is being developed to enable delivery without open-heart surgery. Features such as a short frame to limit ventricular protrusion and lower LVOT obstruction risk, along with secure anchoring and improved sealing against paravalvular leaks, are incorporated. The device remains investigational at this stage.
cardiovalve's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
cardiovalve offers Cardiovalve System, TTVR, and TMVR.
cardiovalve has 1 investor. Key investors include Venus MedTech.
Yes. cardiovalve was acquired by Venus MedTech in December 2021.